Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001746372-26-000002

Chief Financial Officer gave up 32,424 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Miller Joseph M Chief Financial Officer 2026-02-20 Shares withheld for taxes −32,424 $14.40 $466,906 556,703 D: show line 1 in the form
Loading xslF345X05/wk-form4_1771880754.xml…